Amarin Corp PLC(AMRN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AMRN Amarin Corp PLC

Pre-Market Trading 11-26 04:37:36 EST

0.5290

-0.0196

-3.57%

High0.5500	Low0.5210	Vol1.38M
Open0.5410	D1 Closing0.5486	Amplitude5.29%
Mkt Cap217.60M	Tradable Cap202.98M	Total Shares411.34M
T/O730.72K	T/O Rate0.36%	Tradable Shares383.70M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"AMRN","market":"US","secType":"STK","nameCN":"Amarin Corp PLC","latestPrice":0.529,"timestamp":1732568400000,"preClose":0.5486,"halted":0,"volume":1380800,"delay":0,"floatShares":383697977,"shares":411338131,"eps":-0.10006,"marketStatus":"Pre-Market Trading","change":-0.0196,"latestTime":"11-26 04:37:36 EST","open":0.541,"high":0.55,"low":0.521,"amount":730722.342528,"amplitude":0.052862,"askPrice":0.596,"askSize":100,"bidPrice":0.4719,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.10006,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1732631400000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":733640400000,"exchange":"NASDAQ","adjPreClose":0.529,"postHourTrading":{"tag":"盘后","latestPrice":0.5374,"preClose":0.529,"latestTime":"19:02 EST","volume":3692,"amount":1971.8643,"timestamp":1732579339567},"volumeRatio":0.7268119177873362,"impliedVol":3.1626,"impliedVolPercentile":0.8333},"requestUrl":"/m/hq/s/AMRN","defaultTab":"news","newsList":[{"id":"2486103179","title":"European Equities Traded in the US as American Depositary Receipts Rising Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2486103179","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486103179?lang=en_us&edition=fundamental","pubTime":"2024-11-26 00:13","pubTimestamp":1732551208,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were advancing on Monday morning, up 0.5% to 1,324.76 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor contract manufacturing company STMicroelectronics  and Spanish bank  Banco Bilbao Vizcaya Argentaria , which rose 5.5% and 2.5%, respectively.They were followed by Spanish bank Banco Santander , which added 2.3%.The decliners from continental Europe were led by Swedish food company Oatly  and Norwegian energy company Equinor , which fell 1.1% and 0.8%, respectively.From the UK and Ireland, the gainers were led by clinical-stage biopharmaceutical company Barinthus Biotherapeutics  and biotech Compass Pathways , which rose 5.1% and 4.1%, respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Amarin  and clinical-stage cell therapy company TC Biopharm , which were each shedding 2.2%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXR70.SGD","BK7095","BRNS","STM.AU","BK4521","BBVA","LU2308191902.HKD","BK4585","IE00BMPRXN33.USD","SAN","EQNR","BK4107","BK7142","BK4212","STM","BK4139","BK4554","AMRN","BK4201","TCBP","CMPS","BK4141","BK4539","SAN.AU","BK4588","BK4207","BK4548","BK4117","OTLY","AFG"],"gpt_icon":1},{"id":"2485674217","title":"BRIEF-Amarin Corp - Nasdaq Granted 180 Days To Regain Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2485674217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485674217?lang=en_us&edition=fundamental","pubTime":"2024-11-23 05:55","pubTimestamp":1732312517,"startTime":"0","endTime":"0","summary":"BRIEF-Amarin Corp - Nasdaq Granted 180 Days To Regain Nasdaq ComplianceNov 22 (Reuters) - Amarin Corporation PLC AMRN.O:AMARIN CORP - NASDAQ GRANTED 180 DAYS TO REGAIN NASDAQ COMPLIANCESource text: [https://tinyurl.com/bdhep7ek]Further company coverage: AMRN.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nFWN3MT15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN","BK4139"],"gpt_icon":0},{"id":"2485217585","title":"Amarin Corp - Nasdaq Granted 180 Days to Regain Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2485217585","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485217585?lang=en_us&edition=fundamental","pubTime":"2024-11-23 05:52","pubTimestamp":1732312346,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nFWN3MT15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AMRN"],"gpt_icon":0},{"id":"2485029812","title":"European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2485029812","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485029812?lang=en_us&edition=fundamental","pubTime":"2024-11-23 00:04","pubTimestamp":1732291478,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending modestly higher late Friday morning, rising 0.19% to 1,316.54 on the S&P Europe Select ADR Index, which is up approxima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPRA","BK4007","BBVA","AKTX","LU0109394709.USD","BK4535","AZN","BK4139","AMRN","LU0889565916.HKD","BNTX","ING","BK4568","BK4548","BK7141","BK4023","LU2417539215.USD","LU2456880835.USD","BK4521","BK4082","TRIB","ASND","LU1829250122.USD","GNFT","BK7142","BK7505","BK4585","LU0320765992.SGD","LU2462157665.USD","BK4551","SAN.AU","TCBP","AFG","BK4588","SLN","BK4207","LU2236285917.USD","SAN","ADAP","BK4107","BK4117","ING.AU","BDRX","EDAP"],"gpt_icon":0},{"id":"2484924768","title":"European Equities Traded in the US as American Depositary Decline Slightly in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2484924768","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484924768?lang=en_us&edition=fundamental","pubTime":"2024-11-20 00:18","pubTimestamp":1732033088,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were edging lower Tuesday morning, declining 0.14% to 1,308.28 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm BioNTech  and internet advertising company Criteo , which rose 5% and 4.6% respectively. They were followed by medical device maker EDAP TMS  and biopharmaceutical company DBV Technologies , which were up 3.4% each.The decliners from continental Europe were led by furniture maker Natuzzi  and biopharmaceutical company Grifols , which fell 8.1% and 7.1% respectively. They were followed by semiconductor company Sequans Communications  and financial services company Banco Santander , which lost 3.1% and 2% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma  and Adaptimmune Therapeutics , which climbed 7.6% and 5.4% higher respectively. They were followed by biopharmaceutical company Amarin  and utility company Nat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NGG","GRFS","BK4141","BK4548","ADAP","AFG","BK4162","SQNS","NTZ","BK4568","PUK","CRTO","BNTX","SAN.AU","BK4588","AKTX","SLN","BK4207","BK4585","BK4208","BK4521","MREO","BK4551","BK4532","BK4107","BK4505","BK4139","VRNA","EDAP","IE00BFMHRM44.USD","BK4117","BK4082","BK4095","BK7142","AMRN","SAN","BK4009","BK4535","BK4007","DBVT"],"gpt_icon":0},{"id":"2483831633","title":"European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2483831633","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483831633?lang=en_us&edition=fundamental","pubTime":"2024-11-14 23:59","pubTimestamp":1731599997,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.89% to 1,323.86 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Grifols  and petroleum refiner Equinor , which rose 6% and 3.9% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria  and biotech firm BioNTech , which were up 2.7% and 1.7% respectively.The decliners from continental Europe were led by biopharmaceutical companies Genfit  and Cellectis , which fell 9.7% and 4% respectively. They were followed by biopharmaceutical company DBV Technologies  and medical device maker EDAP TMS , which dropped 2.9% and 2.1% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics  and insurance provider Prudential , which increased 7.1% and 2.5% respectively. They were followed by communications company WPP  and cruise line operator Carnival , whic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","BK4535","BNTX","BK4162","BK4009","DAVA.AU","BK4107","EQNR","WPP","WPP.AU","BK4007","AKTX","BK4207","GNFT","PUK","GRFS","CLLS","EDAP","BK4568","TRIB","DAVA","BK4117","AFG","BK4142","BK4201","BK4585","BK4134","BK4588","BK4548","BK4551","AMRN","LU0084288595.USD","ADAP","BK4139","DBVT","BBVA","LU0648005311.SGD","CUK"],"gpt_icon":0},{"id":"2482638734","title":"European Equities Traded in the US as American Depositary Move Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2482638734","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482638734?lang=en_us&edition=fundamental","pubTime":"2024-11-12 00:06","pubTimestamp":1731341161,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving higher late Monday morning, rising 0.35% to 1,339.76 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet browser company Opera  and pharmaceutical company Ascendis Pharma , which rose 4.8% and 3.3% respectively. They were followed by pharmaceutical company Novo Nordisk  and internet advertising firm Criteo , which were up 2.9% and 2% respectively.The decliners from continental Europe were led by accommodations booking company trivago  and biotech firm Evaxion Biotech , which fell 2.4% and 1.8% respectively. They were followed by medical device maker Edap  and telecommunications operator Telefonica , which were down 1.7% and 1.6% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana  and Akari Therapeutics , which climbed 6.3% and 5.2% respectively. They were followed by financial services company Barclays  and software firm E","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BHP.AU","BK4117","BK4532","AFG","BK4521","DAVA.AU","CRTO","EVAX","TEF","BK7095","NVO","BK7507","BHP","NCNA","BK7511","ASND","BK4139","LU0889565916.HKD","LU1093756168.USD","TRIB","BK4023","BK4082","OPRA","BK4588","LU1093756325.SGD","AMRN","TRVG","BK4134","TCBP","LU0084288595.USD","LU0154236417.USD","NVO.AU","AKTX","BK4007","BK4585","BCS","LU0320765992.SGD","BK4207","IE00BKVL7J92.USD","IE00BFMHRM44.USD","BK4107","BK7104","BK4077","IE00BZ1G4Q59.USD","BK4168","LU0109394709.USD","LU0648005311.SGD","DAVA","BK4009","EDAP"],"gpt_icon":1},{"id":"2482895537","title":"Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Scientific Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2482895537","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482895537?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:00","pubTimestamp":1731330000,"startTime":"0","endTime":"0","summary":"DUBLIN and BRIDGEWATER, N.J., Nov.  11, 2024  (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that investigators will present an additional subgroup analysis from the landmark","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/11/2978267/18362/en/Investigators-to-Present-New-REDUCE-IT-Subanalysis-of-VASCEPA-VAZKEPA-icosapent-ethyl-in-Patients-With-and-Without-Coronary-Artery-Disease-History-and-Mechanistic-Data-on-Eicosapen.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4090","BK4117","BK4588","ARE","BK4139","BK4223","AFG","BK4585","IPE","BK4194","BK4153","TG","BK4225","AMRN"],"gpt_icon":1},{"id":"2481066535","title":"Top Analyst Reports for Walmart, Southern Company & Intercontinental Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2481066535","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481066535?lang=en_us&edition=fundamental","pubTime":"2024-11-06 05:33","pubTimestamp":1730842380,"startTime":"0","endTime":"0","summary":"Tuesday, November 5, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NOcNUy7474jJV7SYlrCPWw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c0a2454286e1a81fe39fbe8c46c256d8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NOcNUy7474jJV7SYlrCPWw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c0a2454286e1a81fe39fbe8c46c256d8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-analyst-reports-walmart-southern-213300659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICE","ILMN","IE00BGHQF748.EUR","BK4581","LU0640476718.USD","BK4566","BK4567","AMRN","IE00BN0W2T93.GBP","LU0211327993.USD","LU1150488218.USD","LU0310799852.SGD","LU2237443382.USD","ENB","CL","KLAC","IE00BQXX3C00.GBP","LU0648001328.SGD","FDX","SO","BK4157","LU0661504455.SGD","IDT","IE00B29SXK94.USD","STT","LU0238689110.USD","LU2237957811.SGD","LU1280957306.USD","LU1153585028.USD","BK4172","QRVO","BK4548","BK4534","CWT","LU0052756011.USD","LU0949170772.SGD","SOJE","LU0251131958.USD","LU0323591593.USD","APTV","ZBRA","WMT","WAT","BK4131","URI","LU2360107325.USD","LU0130102774.USD","BK4121","SOJD","LU2237443622.USD"],"gpt_icon":0},{"id":"2480331368","title":"European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2480331368","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480331368?lang=en_us&edition=fundamental","pubTime":"2024-11-01 23:15","pubTimestamp":1730474147,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rallying late Friday morning, rising 0.98% to 1,367.20 on the S&P Europe Select ADR Index, but were still down 1.4% for the week","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4095","LYG","BK4117","EVAX","AFG","BK4521","GNFT","CRTO","BK4551","SAN","BK4548","BNTX","BK4139","CUK","TRIB","BK7142","BK4142","BK4082","BK4588","BK4535","AMRN","SLN","SQNS","SAN.AU","AKTX","BK4007","BK4585","BK4207","BBVA","NTZ","BK4141","BK4107","IE00BFMHRM44.USD","BK4568","BK4009","ADAP"],"gpt_icon":0},{"id":"2480836760","title":"Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2480836760","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480836760?lang=en_us&edition=fundamental","pubTime":"2024-11-01 22:18","pubTimestamp":1730470680,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics, Inc. KYMR reported a loss of 82 cents per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 83 cents. In the year-ago quarter, Kymera reported a loss of 90 cents per share.Collaboration revenues totaled $3.7 million, which missed the Zacks Consensus Estimate of $9 million. The reported figure increased 20.8% from the year-ago level.Collaboration revenues in the third quarter were mostly earned due to the company’s association with bigwig Sanofi SNY.Shares of KYMR have surged 81.3% year to date against the industry’s decline of 3.6%.Kymera Therapeutics, Inc. price-consensus-eps-surprise-chart | Kymera Therapeutics, Inc. Quote. In October, Kymera initiated dosing in the phase I healthy volunteer clinical trial evaluating single and multiple ascending doses of KT-621, a potent and selective oral degrader of STAT6.Sanofi informed Kymera about the decision to expand the studies after a review of preliminary safety and efficacy d","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kymera-q3-loss-narrower-expected-141800644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","AMRN","LU2065169927.USD","SNY","BK4007","BK4139","LU2065170008.USD","LU2065171311.SGD","FOLD","KYMR","IE00BFXG1179.USD","LU2065171402.SGD","BK4588"],"gpt_icon":0},{"id":"2480402785","title":"Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2480402785","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480402785?lang=en_us&edition=fundamental","pubTime":"2024-11-01 15:19","pubTimestamp":1730445571,"startTime":"0","endTime":"0","summary":"Total Net Revenue: $42.3 million in Q3 2024, down from $66.1 million in Q3 2023.U.S. Product Revenue: $30.6 million in Q3 2024, compared to $62.4 million in Q3 2023.European Net Product Revenue: $4.3 million, a $3.5 million increase over the prior year period.Gross Margin: 38% in Q3 2024, compared to 64% in the prior year period.Total Operating Expenses: $41.4 million in Q3 2024, a reduction of approximately $10 million from the prior year period.GAAP Net Loss: $25.1 million in Q3 2024, compared to a $19.3 million loss in the prior year period.Cash and Investments: $306 million as of September 30, 2024.GuruFocus has detected 3 Warning Signs with AMRN.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Amarin Corp PLC  is expanding its global reach with partnerships in nine countries, including recent launches in Australia and China.The company reported a GAAP net loss of $25.1 million for Q3 2024, up from a $19.3 million loss in the prior","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/O2Ux0BpwOOa18_updI7iBQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a555cb4a88b42327405b082778327eeb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/O2Ux0BpwOOa18_updI7iBQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a555cb4a88b42327405b082778327eeb"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amarin-corp-plc-amrn-q3-071931759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMRN"],"gpt_icon":0},{"id":"2479037695","title":"European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2479037695","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479037695?lang=en_us&edition=fundamental","pubTime":"2024-10-31 23:15","pubTimestamp":1730387704,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were falling significantly lower late Thursday morning, dropping 1.4% to 1,347.70 on the S&P Europe Select ADR Index.From continental","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SAN","SHEL","LU2236285917.USD","BK4505","BTI","BK4207","LU0300736492.USD","BK4139","BK4588","BK4009","EVAX","TCBP","BK7142","MTLS","LU0320765992.SGD","BK4142","LU0320765646.SGD","BK4023","AFG","BK4201","CUK","EQNR","IE00BFMHRM44.USD","BK4521","BK4585","SQNS","TRIB","BK4158","BK7119","AMRN","BTI.AU","BUD.AU","BK4141","CRTO","LU0098860793.USD","BK4117","LU0889565916.HKD","SAN.AU","BK4075","BUD","BK4546","ARGX","ADAP","LU1162221912.USD","LU0109394709.USD","BK7062","LU0300736062.USD","BK4082","BK4107","SNN"],"gpt_icon":0},{"id":"2479037318","title":"Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2479037318","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479037318?lang=en_us&edition=fundamental","pubTime":"2024-10-31 21:32","pubTimestamp":1730381520,"startTime":"0","endTime":"0","summary":"Amarin Corporation plc AMRN reported anadjusted loss of 5 cents per share for thethird quarter of2024, which was in line with the Zacks Consensus Estimate. The company had reported breakeven earnings in the year-ago quarter.Total revenues were $42.3 million, which missed the Zacks Consensus Estimate of $44 million. Revenues declined 36% from the year-ago quarter’s levels, owing to lower product revenues.Amarin’s shares were down 2.9% in after-hours trading on Oct. 30, following the announcement of the results.Year to date, the stock has plunged 30.8% compared with the industry’s decline of 3.2%.U.S. product revenues from Vascepa totaled $30.6 million, declining almost 51% from the year-ago quarter’s level as rising generic competition continued to hurt sales volumes. The drug’s U.S. sales missed our model estimate of $34.8 million.Selling, general and administrative expenses totaled $36.9 million, down almost 18.9% year over year. This downside was due to cost optimization efforts in A","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amarins-q3-earnings-line-revenues-133200661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMRN"],"gpt_icon":0},{"id":"2479723370","title":"Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2479723370","media":"Motley Fool Transcribing","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479723370?lang=en_us&edition=fundamental","pubTime":"2024-10-31 14:00","pubTimestamp":1730354415,"startTime":"0","endTime":"0","summary":"AMRN earnings call for the period ending September 30, 2024.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com/earnings/call-transcripts/2024/10/31/amarin-plc-amrn-q3-2024-earnings-call-transcript/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_motley_transcript","symbols":["AMRN"],"gpt_icon":1},{"id":"2479712643","title":"Amarin Corporation PLC reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2479712643","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479712643?lang=en_us&edition=fundamental","pubTime":"2024-10-31 10:37","pubTimestamp":1730342255,"startTime":"0","endTime":"0","summary":"Amarin Corporation PLC reports results for the quarter ended in September 30 - Earnings Summary  Amarin Corporation PLC AMRN.OQ reported a quarterly adjusted loss of 6 cents per share for the quarter ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nL8N3M706N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN"],"gpt_icon":0},{"id":"2479761704","title":"Amarin: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2479761704","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479761704?lang=en_us&edition=fundamental","pubTime":"2024-10-31 05:21","pubTimestamp":1730323319,"startTime":"0","endTime":"0","summary":"DUBLIN  — DUBLIN  — Amarin Corp. PLC  on Wednesday reported a loss of $25.1 million in its third quarter.The Dublin-based company said it had a loss of 6 cents per share. Losses, adjusted for stock option expense, were 5 cents per share.The biopharmaceutical company posted revenue of $42.3 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $43.8 million.In the final minutes of trading on Wednesday, the company's shares hit 60 cents. A year ago, they were trading at 69 cents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amarin-q3-earnings-snapshot-212159946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMRN"],"gpt_icon":0},{"id":"2479757922","title":"Amarin Corp Q3 2024 GAAP EPS $(0.06) Misses $(0.05) Estimate, Sales $42.300M Miss $44.510M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2479757922","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479757922?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:13","pubTimestamp":1730319210,"startTime":"0","endTime":"0","summary":"Amarin Corp (NASDAQ:AMRN) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent.  The company reported quarterly sales of $42.300 million which missed the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/10/41636235/amarin-corp-q3-2024-gaap-eps-0-06-misses-0-05-estimate-sales-42-300m-miss-44-510m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Amarin Corp Q3 2024 GAAP EPS $(0.06) Misses $(0.05) Estimate, Sales $42.300M Miss $44.510M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN"],"gpt_icon":0},{"id":"2479757599","title":"Amarin Q3 Operating Expenses USD 41.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2479757599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479757599?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:05","pubTimestamp":1730318706,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nPLX869D62:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AMRN"],"gpt_icon":0},{"id":"2479752094","title":"Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2479752094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479752094?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:05","pubTimestamp":1730318706,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA6YBSVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AMRN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amarincorp.com","stockEarnings":[{"period":"1week","weight":0.1376},{"period":"1month","weight":-0.0912},{"period":"3month","weight":-0.1481},{"period":"6month","weight":-0.3702},{"period":"1year","weight":-0.3242},{"period":"ytd","weight":-0.392}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.","yearOnYearQuotes":[{"month":1,"riseRate":0.483871,"avgChangeRate":0.121478},{"month":2,"riseRate":0.290323,"avgChangeRate":-0.049611},{"month":3,"riseRate":0.483871,"avgChangeRate":0.007044},{"month":4,"riseRate":0.419355,"avgChangeRate":0.05555},{"month":5,"riseRate":0.34375,"avgChangeRate":-0.015384},{"month":6,"riseRate":0.46875,"avgChangeRate":-0.009779},{"month":7,"riseRate":0.258065,"avgChangeRate":-0.027767},{"month":8,"riseRate":0.548387,"avgChangeRate":0.063939},{"month":9,"riseRate":0.419355,"avgChangeRate":0.077324},{"month":10,"riseRate":0.387097,"avgChangeRate":-0.05003},{"month":11,"riseRate":0.580645,"avgChangeRate":0.115282},{"month":12,"riseRate":0.466667,"avgChangeRate":-0.019059}],"exchange":"NASDAQ","name":"Amarin Corp PLC","nameEN":"Amarin Corp PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amarin Corp PLC(AMRN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amarin Corp PLC(AMRN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amarin Corp PLC,AMRN,Amarin Corp PLC股票,Amarin Corp PLC股票老虎,Amarin Corp PLC股票老虎国际,Amarin Corp PLC行情,Amarin Corp PLC股票行情,Amarin Corp PLC股价,Amarin Corp PLC股市,Amarin Corp PLC股票价格,Amarin Corp PLC股票交易,Amarin Corp PLC股票购买,Amarin Corp PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amarin Corp PLC(AMRN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amarin Corp PLC(AMRN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction